logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10632101 B1

PDFFull Text
Date of Patent:
Apr. 28, 2020

Filed:

Jul. 06, 2017

Methods and compositions for supporting endogenous systems related to life span

Applicant:

Usana Health Sciences, Inc., Salt Lake City, UT (US);

Inventors:

Mark Brown, Salt Lake City, UT (US);

John Cuomo, Salt Lake City, UT (US);

Jeremy Tian, Salt Lake City, UT (US);

Assignee:

USANA Health Sciences, Inc., Salt Lake City, UT (US);

Attorneys:

Kirton McConkie

Brian Tucker

Primary Examiner:

Alma Pipic

Int. Cl.
CPC ...
A23L 33/15 (2016.01); A23L 33/16 (2016.01); A61K 47/55 (2017.01); A61K 31/385 (2006.01); A61K 9/20 (2006.01); A61K 31/05 (2006.01); A61K 31/12 (2006.01); A61K 31/353 (2006.01); A61K 36/63 (2006.01); A61K 31/7048 (2006.01); A61K 31/015 (2006.01); A61K 31/232 (2006.01); A61K 31/375 (2006.01); A61K 31/355 (2006.01); A61K 31/593 (2006.01); A61K 31/122 (2006.01); A61K 31/4415 (2006.01); A61K 31/51 (2006.01); A61K 31/525 (2006.01); A61K 31/714 (2006.01); A61K 36/82 (2006.01); A61K 31/197 (2006.01); A61K 31/4188 (2006.01); A61K 31/455 (2006.01); A61K 31/519 (2006.01); A61K 31/01 (2006.01); A61K 31/047 (2006.01); A61K 31/14 (2006.01); A23L 33/00 (2016.01); A23L 33/155 (2016.01); A23L 33/10 (2016.01); A61K 45/06 (2006.01); A61K 31/382 (2006.01); A61K 31/352 (2006.01); A61K 31/065 (2006.01);
U.S. Cl.
CPC ...
A61K 31/385 (2013.01); A23L 33/10 (2016.08); A23L 33/15 (2016.08); A23L 33/155 (2016.08); A23L 33/16 (2016.08); A23L 33/40 (2016.08); A61K 9/20 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 31/01 (2013.01); A61K 31/015 (2013.01); A61K 31/047 (2013.01); A61K 31/05 (2013.01); A61K 31/065 (2013.01); A61K 31/12 (2013.01); A61K 31/122 (2013.01); A61K 31/14 (2013.01); A61K 31/197 (2013.01); A61K 31/232 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/382 (2013.01); A61K 31/4188 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/593 (2013.01); A61K 31/7048 (2013.01); A61K 31/714 (2013.01); A61K 36/63 (2013.01); A61K 36/82 (2013.01); A61K 45/06 (2013.01); A61K 47/551 (2017.08); A23V 2002/00 (2013.01);
Abstract

A composition for supporting endogenous systems related to life span, inhibiting mTOR, and reducing damage associated with oxidative phosphorylation. The composition comprises an upregulating compound mixture configured to upregulate an endogenous antioxidant system, an exogenous antioxidant mixture configured to inhibit oxidation of biomolecules by reactive oxygen species, and a mineral mixture configured to provide one or more cofactors to a endogenous antioxidant enzyme. The endogenous antioxidant system includes regulation of mitophagy through mTOR mediated regulation, and a Nrf2 transcription factors that promotes transcription of antioxidant genes.

Find Patent Forward Citations

Loading…